First Melanoma CoP Meeting – Immunotherapy‑Related Adrenal Insufficiency
We are pleased to invite you to our first Melanoma CoP meeting for 2026. This session will focus on immunotherapy‑related toxicity of adrenal insufficiency, including key aspects of clinical presentation, diagnosis, management, and the support available for patients and clinicians.
We are delighted to have an expert panel of presenters, including:
- Tania Yarndley, Endocrine Nurses Society of Australasia
- Sarah Fostekew, Endocrine Nurses Society of Australasia
- Bronwyn Monro, Australia Addison’s Disease Association Incorporated
This session will provide valuable insights into recognising and managing adrenal insufficiency in the context of immunotherapy, with perspectives from both clinicians and patient advocacy.
Date: 19 February 2026
Time: 1:00 PM - 2:00 PM
Meeting link: teams.microsoft.com/meet/49178179280059?p=vfIG3R3EmrqZZrFJ5b
Created: 23 Jan 2026 03:01:51 PM
All Replies (0)
There are no replies to this discussion.